All Outputs (2)

A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid. (2024)
Presentation / Conference
STOIBER, A., GRAY, G., SAILER, G., HUF, W. and TONNA, A. 2024. A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid. Poster presented at the 28th European Association of Hospital Pharmacists (EAHP) annual congress 2024 (EAHP 2024): sustainable healthcare; opportunities and strategies, 20-22 March 2024, Bordeaux, France.

Paxlovid ®, the only orally available COVID drug, consists of two main components: Nirmatrelvir and Ritonavir. Ritonavir is known for the potent inhibition of CYP (cytochrome P450) enzymes in the liver mainly of CYP3A4, resulting in a large number of... Read More about A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid..

Using authentic learning environments to bridge the theory-practice gap in pharmacy education. (2023)
Presentation / Conference
DEPASQUALE, C., ADAMS, L. and GRAY, G. 2023. Using authentic learning environments to bridge the theory-practice gap in pharmacy education. Presented at the 2023 International higher education teaching and learning annual conference (HETL 2023): re-imagining education: collaboration and compassion, 12-14 June 2023, Aberdeen, UK, poster P18.

Creating authentic learning environments highlights real-world relevance to students and contributes to their readiness for practice. Academics at Robert Gordon University used an exercise - in which student pharmacists dispense prescriptions in a si... Read More about Using authentic learning environments to bridge the theory-practice gap in pharmacy education..